Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Bojan Vrtovec, Piergiuseppe Agostoni et al.|Journal of Cardiovascular Pharmacology|2020Cited by 111
Cardiovascular risk assessment in low-resource settingsPietro Amedeo Modesti, Gianfranco Parati, Piergiuseppe Agostoni et al.|Journal of Hypertension|2014Cited by 89
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical UseZoltán Papp, Bojan Vrtovec, Piergiuseppe Agostoni et al.|Cardiac failure review|2020Cited by 67
Post‐discharge arrhythmic risk stratification of patients with acute myocarditis and life‐threatening ventricular tachyarrhythmiasPiero Gentile, Gianfranco Sinagra, Mark R. Hazebroek et al.|European Journal of Heart Failure|2021Cited by 40
Evolution in the Diagnosis and Treatment of Myocarditis in Recent Years: State of the ArtJeness Campodonico, Carlo Vignati, Chiara Lauri et al.|Journal of Clinical Medicine|2025Cited by 3